HERA-CD40L

N/A

Report date: 2024/07/30 14:17:01

Base Information

Drug NameHERA-CD40L
Drug Alias NameHERA-CD40LHERA-CD-40-L
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCD40 ligand inhibitors
TargetsCD40 ligand
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApogenix Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesApogenix Gmbh
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A